报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | -2.39% | 31.32% | -18.32% | 113/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | -2.02% | 33.77% | -90.57% | 115/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | -1.06% | -43.24% | 83.36% | 117/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | -6.37% | -2.41% | -83.05% | 115/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | -3.48% | -157.78% | -14.1% | 115/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | -3.05% | -53.27% | -312.16% | 118/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | -0.74% | -48% | 88.1% | 112/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | -6.22% | -1103.23% | -360.74% | 118/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | -1.35% | -104.52% | 32.16% | 109/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | -1.99% | -110.46% | -298% | 117/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | -0.5% | -103.26% | -180.65% | 102/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 0.62% | -96.76% | -97.92% | 116/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 29.85% | 45.47% | 56.94% | 11/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 19.02% | 171.71% | 24.15% | 14/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 15.32% | 801.18% | -19.87% | 8/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 19.12% | 227.96% | -6.82% | 54/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | 20.52% | 342.24% | 193.14% | 25/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-06-30 | 7% | 152.71% | 311.76% | 58/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
2020-03-31 | 1.7% | 39.34% | -70.84% | 47/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
2019-12-31 | 5.83% | -30.43% | 25.65% | 92/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
2019-09-30 | 4.64% | -48.62% | 67.51% | 50/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
2019-06-30 | 2.77% | -60.26% | 127.05% | 55/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
2019-03-31 | 1.22% | -69.58% | -85.44% | 40/129 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
2018-12-31 | 8.38% | -43.64% | -7.2% | 76/129 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
2018-09-30 | 9.03% | -24.81% | 29.56% | 29/129 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
2018-06-30 | 6.97% | -12.44% | 73.82% | 20/129 | 3.21% | 明德生物 | 14.54% | 行业排名> |
2018-03-31 | 4.01% | 2.04% | -73.03% | 14/129 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
2017-12-31 | 14.87% | 14.21% | 23.81% | 45/129 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
2017-09-30 | 12.01% | 1.26% | 50.88% | 16/129 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
2017-06-30 | 7.96% | 19.7% | 102.54% | 18/129 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
2017-03-31 | 3.93% | 6.22% | -69.82% | 9/129 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
2016-12-31 | 13.02% | -12.62% | 9.78% | 45/129 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
2016-09-30 | 11.86% | -7.27% | 78.35% | 8/129 | 8.69% | 安图生物 | 28% | 行业排名> |
2016-06-30 | 6.65% | -10.62% | 79.73% | 19/129 | 6.26% | 明德生物 | 23.29% | 行业排名> |
2016-03-31 | 3.7% | -3.39% | -75.17% | 4/129 | 2.14% | 健帆生物 | 7.75% | 行业排名> |
2015-12-31 | 14.9% | 168.47% | 16.5% | 25/129 | 15.95% | 大博医疗 | 55.39% | 行业排名> |
2015-09-30 | 12.79% | 303.47% | 71.91% | 5/129 | 7.79% | 鱼跃医疗 | 17.33% | 行业排名> |
2015-06-30 | 7.44% | 392.72% | 94.26% | 17/129 | 7.77% | 明德生物 | 29.93% | 行业排名> |
2015-03-31 | 3.83% | 463.24% | -30.99% | 11/129 | 3.2% | 中源协和 | 14.44% | 行业排名> |